Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
株式のランク
#4268
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
株価
$2.22
時価総額
$3.71B
変化（1日）
-0.13%
変化（1年）
-7.34%
国
CN
取引 Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
カテゴリー
Healthcare
Shijiazhuang Yiling Pharmaceutical Co., Ltd.（002603）の配当履歴
Shijiazhuang Yiling Pharmaceutical Co., Ltd.（証券コード：002603）は合計で14回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：$2.68
配当利回り（TTM）：0.0532
すべての配当の合計（株式分割調整済み）は：$2.68
配当利回り（TTM）：0.0532
2012から2026までのShijiazhuang Yiling Pharmaceutical Co., Ltd.（002603）の配当履歴
年間配当支払い
| 年 | 配当（株式分割調整済み） | 変化 |
|---|---|---|
| 2026 (TTM) | $0.3 | 0.00% |
| 2025 | $0.3 | 0.00% |
| 2024 | $0.3 | -40.00% |
| 2023 | $0.5 | 66.67% |
| 2022 | $0.3 | -58.00% |
| 2021 | $0.7143 | 399.86% |
| 2020 | $0.1429 | 100.14% |
| 2019 | $0.0714 | 0.00% |
| 2018 | $0.0714 | 0.00% |
| 2017 | $0.0714 | 0.00% |
| 2016 | $0.0714 | 100.00% |
| 2015 | $0.0357 | 0.00% |
| 2014 | $0.0357 | 0.00% |
| 2013 | $0.0357 | 29.82% |
| 2012 | $0.0275 | 0.00% |
すべての配当支払いの一覧
| 年 | 配当 | 変化 |
|---|---|---|
| 2026 (TTM) | $0.3 | 0.00% |
| 2025 | $0.3 | 0.00% |
| 2024 | $0.3 | -40.00% |
| 2023 | $0.5 | 66.67% |
| 2022 | $0.3 | -70.00% |
| 2021 | $1.00 | 400.00% |
| 2020 | $0.2 | 100.00% |
| 2019 | $0.1 | 0.00% |
| 2018 | $0.1 | 0.00% |
| 2017 | $0.1 | 0.00% |
| 2016 | $0.1 | 0.00% |
| 2015 | $0.1 | 0.00% |
| 2014 | $0.1 | 0.00% |
| 2013 | $0.1 | 0.00% |
| 2012 | $0.1 | 0.00% |
同業他社や競合企業の配当履歴
| 企業 | 配当支払い回数 | 国 |
|---|---|---|
| 23.00% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
